Wells Fargo’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $119K | Sell |
8,629
-6,801
| -44% | -$105K | ﹤0.01% | 5010 |
|
|
2025
Q4 | $241K | Buy |
15,430
+8,240
| +115% | +$152K | ﹤0.01% | 4960 |
|
|
2025
Q3 | $174K | Buy |
7,190
+2,334
| +48% | +$86.6K | ﹤0.01% | 5008 |
|
|
2025
Q2 | $175K | Buy |
+4,856
| New | +$127K | ﹤0.01% | 4847 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7263 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7195 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7081 |
|
|
2024
Q2 | – | Hold |
0
| – | -$85 | – | 7461 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6702 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6842 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6840 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6835 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6714 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6698 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7371 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7493 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6182 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5753 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6247 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5880 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6139 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5271 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6234 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6822 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6796 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6739 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6723 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6622 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5968 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6311 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6246 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5814 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5897 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6151 |
|
|
2017
Q3 | – | Hold |
0
| – | -$1K | – | 6465 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6138 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6236 |
|
|
2016
Q4 | – | Hold |
0
| – | -$2K | – | 6448 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6055 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 5789 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5776 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5368 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 5441 |
|
|
2014
Q2 | – | Hold |
0
| – | -$7K | – | 6281 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5477 |
|
Other funds holding TNXP
VCM
JHC
Wells Fargo's TNXP Position: Q1 2026 in Review
Wells Fargo reduced its Tonix Pharmaceuticals (TNXP) stake by 44% in Q1 2026, selling an estimated $105K and leaving 8,629 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #5010.
Wells Fargo first reported a position in TNXP in Q2 2025 and has held it in 4 quarters since. The position peaked at $241K in Q4 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.
- Wells Fargo held 8,629 shares of Tonix Pharmaceuticals worth $119K as of Q1 2026.
- Wells Fargo sold 6,801 Tonix Pharmaceuticals shares in Q1 2026, an estimated $105K.
- Tonix Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5010 holding.
- Wells Fargo first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
- Wells Fargo's Tonix Pharmaceuticals position peaked at $241K in Q4 2025.
- 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.